| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Neuroendocrine | 5 | 2014 | 740 | 1.090 |
Why?
|
| Carcinoma, Ductal, Breast | 10 | 2013 | 1225 | 0.720 |
Why?
|
| Breast Neoplasms | 26 | 2014 | 16073 | 0.710 |
Why?
|
| Breast Neoplasms, Male | 3 | 2014 | 231 | 0.530 |
Why?
|
| ELAV Proteins | 1 | 2013 | 17 | 0.450 |
Why?
|
| Oncogene Proteins | 7 | 2008 | 362 | 0.410 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2002 | 1799 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2008 | 2564 | 0.380 |
Why?
|
| Cytoplasm | 1 | 2013 | 654 | 0.380 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 6 | 2013 | 694 | 0.340 |
Why?
|
| Receptor, ErbB-2 | 6 | 2013 | 2629 | 0.330 |
Why?
|
| Genetic Heterogeneity | 1 | 2010 | 317 | 0.310 |
Why?
|
| Fusion Proteins, bcr-abl | 7 | 2008 | 1128 | 0.280 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 622 | 0.270 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 649 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2011 | 2392 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 6 | 2014 | 4064 | 0.220 |
Why?
|
| Tyrosine | 5 | 2001 | 508 | 0.190 |
Why?
|
| Ultrasonography, Mammary | 3 | 2014 | 383 | 0.190 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2012 | 347 | 0.170 |
Why?
|
| Aged, 80 and over | 10 | 2014 | 30845 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 10 | 2002 | 66 | 0.160 |
Why?
|
| Aged | 18 | 2014 | 73018 | 0.160 |
Why?
|
| Adult | 18 | 2014 | 80872 | 0.150 |
Why?
|
| Immunohistochemistry | 6 | 2013 | 7711 | 0.150 |
Why?
|
| Middle Aged | 19 | 2014 | 89661 | 0.150 |
Why?
|
| Female | 28 | 2014 | 147624 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 4061 | 0.130 |
Why?
|
| Biomarkers, Tumor | 7 | 2013 | 10641 | 0.120 |
Why?
|
| Neoplasm Staging | 6 | 2014 | 13883 | 0.120 |
Why?
|
| Gene Amplification | 2 | 2010 | 745 | 0.120 |
Why?
|
| Gene Expression Profiling | 7 | 2013 | 5228 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2014 | 9065 | 0.120 |
Why?
|
| Ki-67 Antigen | 2 | 2013 | 682 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 4893 | 0.110 |
Why?
|
| Humans | 36 | 2014 | 270969 | 0.110 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 35 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2011 | 2508 | 0.110 |
Why?
|
| Receptors, Estrogen | 5 | 2012 | 2131 | 0.110 |
Why?
|
| Prognosis | 6 | 2013 | 22348 | 0.110 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2013 | 53 | 0.110 |
Why?
|
| Lymphatic Metastasis | 3 | 2011 | 4940 | 0.110 |
Why?
|
| Paget's Disease, Mammary | 1 | 2012 | 41 | 0.100 |
Why?
|
| Adenomyoepithelioma | 1 | 2011 | 9 | 0.100 |
Why?
|
| Synaptophysin | 1 | 2011 | 79 | 0.100 |
Why?
|
| Chromogranin A | 1 | 2011 | 65 | 0.100 |
Why?
|
| Breast Diseases | 1 | 2013 | 205 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2011 | 170 | 0.090 |
Why?
|
| Mastectomy | 3 | 2012 | 1569 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2011 | 395 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2013 | 5360 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2014 | 642 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2012 | 848 | 0.090 |
Why?
|
| SEER Program | 1 | 2014 | 1028 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 325 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2001 | 335 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2011 | 302 | 0.090 |
Why?
|
| Gene Expression | 4 | 2013 | 3574 | 0.090 |
Why?
|
| Disease-Free Survival | 5 | 2013 | 10092 | 0.080 |
Why?
|
| Mammography | 2 | 2014 | 1029 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 796 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 11638 | 0.080 |
Why?
|
| Annexin A1 | 1 | 2008 | 40 | 0.080 |
Why?
|
| K562 Cells | 4 | 2008 | 341 | 0.080 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 1806 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2004 | 4720 | 0.080 |
Why?
|
| Lipocalins | 1 | 2008 | 54 | 0.080 |
Why?
|
| Acute-Phase Proteins | 1 | 2008 | 81 | 0.080 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2008 | 2597 | 0.080 |
Why?
|
| COS Cells | 5 | 2002 | 387 | 0.080 |
Why?
|
| Glycolysis | 1 | 2011 | 530 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2013 | 10282 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-abl | 2 | 1999 | 82 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 992 | 0.070 |
Why?
|
| Tumor Burden | 1 | 2013 | 2020 | 0.070 |
Why?
|
| Exons | 3 | 2002 | 1346 | 0.070 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 1061 | 0.070 |
Why?
|
| Autophagy | 1 | 2013 | 929 | 0.070 |
Why?
|
| Breast | 3 | 2007 | 1361 | 0.070 |
Why?
|
| Lymph Nodes | 3 | 2012 | 3037 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 562 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2007 | 568 | 0.060 |
Why?
|
| Receptors, GABA-A | 1 | 2005 | 80 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 4867 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2006 | 182 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2011 | 1645 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 3 | 2013 | 5156 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2013 | 34335 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2001 | 83 | 0.060 |
Why?
|
| Glucose | 1 | 2011 | 1272 | 0.060 |
Why?
|
| Transfection | 5 | 2002 | 2987 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2005 | 249 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2007 | 590 | 0.060 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 1307 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 5250 | 0.060 |
Why?
|
| Heat Shock Transcription Factors | 2 | 2013 | 44 | 0.050 |
Why?
|
| Recurrence | 1 | 2010 | 4889 | 0.050 |
Why?
|
| Phosphoserine | 1 | 2002 | 109 | 0.050 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2004 | 326 | 0.050 |
Why?
|
| Phosphorylation | 6 | 2001 | 4887 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2001 | 158 | 0.050 |
Why?
|
| Cell Division | 3 | 2001 | 2555 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2013 | 447 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6034 | 0.050 |
Why?
|
| ras Proteins | 2 | 2001 | 784 | 0.050 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2004 | 494 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 1085 | 0.040 |
Why?
|
| Cell Line | 3 | 2012 | 5122 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4182 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 16327 | 0.040 |
Why?
|
| Male | 5 | 2014 | 127769 | 0.040 |
Why?
|
| Moloney murine leukemia virus | 1 | 1999 | 24 | 0.040 |
Why?
|
| Proteins | 2 | 1999 | 1976 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 2258 | 0.040 |
Why?
|
| Animals | 13 | 2012 | 61175 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2013 | 1693 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 656 | 0.040 |
Why?
|
| Genes, erbB-2 | 2 | 2011 | 232 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 7982 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1999 | 246 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7333 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 4458 | 0.040 |
Why?
|
| Catalysis | 1 | 1998 | 251 | 0.040 |
Why?
|
| Survival Rate | 1 | 2011 | 12475 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 619 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 1464 | 0.030 |
Why?
|
| Cell Survival | 2 | 2001 | 3064 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2012 | 1865 | 0.030 |
Why?
|
| Risk Factors | 1 | 2013 | 18036 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 452 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 4281 | 0.030 |
Why?
|
| Receptors, Progesterone | 2 | 2013 | 1413 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2002 | 1290 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1999 | 888 | 0.030 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 1398 | 0.030 |
Why?
|
| src Homology Domains | 3 | 2002 | 127 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 6233 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 2934 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2013 | 5298 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 6107 | 0.030 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2013 | 35 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 14928 | 0.030 |
Why?
|
| Dermis | 1 | 2012 | 65 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 3098 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2011 | 30 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2012 | 39724 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 454 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 196 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2001 | 109 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 761 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2011 | 111 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2011 | 117 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1080 | 0.020 |
Why?
|
| Bridged-Ring Compounds | 1 | 2011 | 184 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7877 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2014 | 751 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 2093 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 776 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 1090 | 0.020 |
Why?
|
| Cadherins | 1 | 2013 | 669 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 315 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 844 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Anthracyclines | 1 | 2011 | 334 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Disease Progression | 2 | 2012 | 6881 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 630 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 718 | 0.020 |
Why?
|
| Lipocalin-2 | 1 | 2008 | 69 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2011 | 719 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 14558 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1098 | 0.020 |
Why?
|
| Forecasting | 1 | 2011 | 705 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 15255 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 506 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2011 | 619 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1340 | 0.020 |
Why?
|
| Metaplasia | 1 | 2009 | 388 | 0.020 |
Why?
|
| Taxoids | 1 | 2011 | 992 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2008 | 146 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 1710 | 0.020 |
Why?
|
| Mice | 4 | 2012 | 35455 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 1942 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2081 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3069 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2006 | 64 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2014 | 12145 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 698 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2001 | 1800 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1999 | 2869 | 0.020 |
Why?
|
| Calcinosis | 1 | 2009 | 437 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 726 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2008 | 580 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 4357 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 750 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 3148 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 201 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 32464 | 0.010 |
Why?
|
| Biopsy | 1 | 2011 | 3502 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 5094 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2011 | 4341 | 0.010 |
Why?
|
| Genes, p53 | 1 | 2008 | 1110 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6269 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 5015 | 0.010 |
Why?
|
| Protein Binding | 2 | 1999 | 3495 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 340 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2002 | 634 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2001 | 119 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 314 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 3218 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 9020 | 0.010 |
Why?
|
| Apoptosis | 2 | 2008 | 7756 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 712 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9466 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2001 | 256 | 0.010 |
Why?
|
| Genomics | 1 | 2011 | 2845 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 966 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 3980 | 0.010 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 1999 | 9 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 3376 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 383 | 0.010 |
Why?
|
| Checkpoint Kinase 2 | 1 | 1999 | 131 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 1999 | 127 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 97 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 845 | 0.010 |
Why?
|
| Genes, abl | 1 | 1998 | 116 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1998 | 201 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 1509 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1998 | 397 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 13261 | 0.010 |
Why?
|
| Aorta | 1 | 2001 | 707 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1997 | 54 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 7210 | 0.010 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 1999 | 436 | 0.010 |
Why?
|
| Plasmids | 1 | 1998 | 843 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 471 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 13336 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1997 | 364 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 5495 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 6181 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 1718 | 0.010 |
Why?
|
| United States | 1 | 2013 | 16325 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 1458 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 3621 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 802 | 0.010 |
Why?
|
| Mutation | 2 | 2008 | 15640 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 622 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 1296 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 2733 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 5677 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1999 | 1872 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 5510 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 4903 | 0.010 |
Why?
|
| Phenotype | 1 | 1998 | 6353 | 0.000 |
Why?
|